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Sterile triploid ﬁsh represent a solution to the problems associated with sexual maturation and escapees
in aquaculture. However, as disease outbreaks continue to cause signiﬁcant economic losses to the in-
dustry, it is essential that the response of triploids to disease and disease treatments be characterised.
The aim of this study was to compare the response of triploid Atlantic salmon to a commercial furun-
culosis vaccine with that of diploid ﬁsh, and to assess the vaccine efﬁcacy in the two ploidies through an
experimental infection with Aeromonas salmonicida. Diploid and triploid Atlantic salmon were injected
intraperitoneally with either phosphate buffered saline, liquid parafﬁn adjuvant or a commercial
furunculosis vaccine. Following vaccination, growth, adhesion scores and a variety of assays to assess
immune function, such as respiratory burst and antibody response, were measured. Vaccination did not
have a signiﬁcant effect on the weight of either ploidy prior to challenge at 750 days. Adhesion scores
were signiﬁcantly higher in vaccinated ﬁsh compared to unvaccinated ﬁsh, although no effect of ploidy
was observed. Ploidy signiﬁcantly affected respiratory burst activity following vaccination, however, with
triploids exhibiting higher activity than diploids. Combined with lower white blood cell numbers
observed in the triploids, it may be that this low cell number is compensated for by increased cellular
activity. Ploidy however, did not have a signiﬁcant effect on complement activity or antibody response,
with signiﬁcantly higher antibody levels detected in all vaccinated ﬁsh compared to unvaccinated con-
trols. In addition, both ploidy groups were well protected following challenge with no difference in the
relative percentage survival. Based on these results, it appears that ploidy does not affect the severity of
adhesions that result post-vaccinate or in the ﬁsh's immune response following vaccination, and the
furunculosis vaccine performs equally well in both diploid and triploid Atlantic salmon.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
In recent years, the Atlantic salmon (Salmo salar) industry has
paid particular attention to the issues associated with sexual
maturation prior to harvest and issues related to escapees [1e4].
Sexual maturation in ﬁsh causes the transfer of energy from normal
somatic growth to gonadal development. This is known to have
adverse effects on body growth rates and ﬂesh quality, and mayers).
r Ltd. This is an open access articleincrease incidences of disease andmortality [5e7]. Sexually mature
ﬁsh that escape from production sites also have the potential to
interact with wild ﬁsh, impacting on the genetics and ﬁtness of the
wild population [8]. Triploid salmon are the only commercially
available and acceptable means of achieving sterility in ﬁsh, and are
increasingly being used as a method to control sexual maturation
[2,4,9,10].
Triploidy can be readily induced through the application of a
hydrostatic or temperature ‘shock’ to newly-fertilised eggs and the
process has been optimised for several commercially important
species in aquaculture including Atlantic salmon, rainbow troutunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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thalmus maximus) and grass carp (Ctenopharyngodon idella)
[4,11e13]. This ‘shock’ treatment prevents second meiotic division
and causes the retention of the second polar body, which results in
three sets of chromosomes rather than two, and in turn sterility in
triploid ﬁsh [11,12]. Importantly, only females appear to be fully
sterile as males have been found to develop gonads, although
sperm is aneuploid and as a result not functional [14]. However,
despite the clear advantages of being sterile, if triploid Atlantic
salmon are to be considered for commercial production, they must
perform equally as well as diploids in all aspects of their biology
and physiology.
Many studies over recent years have investigated triploid
salmon physiology and performance, including effects on egg in-
cubation [9], smoltiﬁcation [15], growth [2,7,16e18], deformity and
cataracts [17,19]. There are very few studies that have focussed on
triploid salmon health and immunity, however. Disease and
resulting health issues are considered one of the largest single
causes of economic losses in aquaculture and, as such, represent a
signiﬁcant constraint to the continued development and success of
the industry [20,21]. Understanding how triploid ﬁsh cope with
health challenges is therefore crucial and it is important to char-
acterise their robustness. Empirical evidence suggests no differ-
ences in mortality of triploid salmon compared to diploid siblings
when challenged with disease in commercial settings, although
few scientiﬁc assessments have been carried out. A study by Frenzl
et al. [22] showed similar infection levels between ploidies when
challenged with the ectoparasite sea lice, Lepeophtheirus salmonis,
following both experimental and natural challenges. However,
there is a clear lack of data on triploid salmon response to bacterial
and viral challenges and conﬂicting results have been reported in
other ﬁsh species [23,24].
Furunculosis, caused by the bacterium Aeromonas salmonicida
subsp. salmonicida, is recognised as one of the most commercially
signiﬁcant infectious diseases of Atlantic salmon [25,26]. This
pathogen causes a haemorrhagic septicaemia, deep ulcerative le-
sions and necrosis of the kidney, and can result in high levels of
mortality [27]. As a result, effective commercial vaccines against
furunculosis have been developed and are widely used in salmon
aquaculture [28]. Application of vaccines can be stressful for the
ﬁsh, and can result in side effects, compromising ﬁsh welfare. In a
study by Fraser et al. [29], it was shown that vaccination with
Norvax MINOVA 6 Vet (Norvax®, Intervet International B.V., Box-
meer, Netherlands), a multivalent vaccine against furunculosis,
classical vibriosis, coldwater vibriosis, and infectious pancreatic
necrosis (IPN), induced higher abdominal adhesions in triploid
salmon, compared with diploid ﬁsh in out of season S0 smolts [29].
Further studies are clearly required to fully elucidate the response
of triploid salmon to infectious agents and vaccination, and to
determine if their responses are signiﬁcantly different from their
diploid counterparts.
The aim of the study was to investigate the response of triploid
salmon to vaccination against furunculosis using a commercially
available vaccine and assess levels of protection elicited by the
vaccine through experimental infection with Aeromonas salmoni-
cida compared with their diploid siblings.
2. Materials and methods
2.1. Fish stock and history
Eggs and milt were obtained from commercial Atlantic salmon
broodstock stripped in October 2012 (Aquagen® Atlantic QTL-
innOVA® IPN/PD strain Norway). Following fertilisation, half of each
egg batch was subjected to a pressure shock (655 bar for 6.25 min,37.5 min post-fertilisation at 8 C) to induce triploidy. Eggs were
then incubated at 6.0 ± 0.5 C until eyed. Eyed eggs (21 December
2012, 372 days,D) were supplied to the University of Stirling fa-
cilities (Howietoun Fish Farm) and incubated in complete darkness
at 7.1 ± 0.3 C until they started to hatch (7 January 2013,
~470e500D). First feeding commenced on 25 February 2013,
(~880D) and temperature gradually increased (8.4 ± 1.3 C). On 28
May 2013, fry were transferred to the Niall Bromage Freshwater
Research Facility (NBFRF), Buckieburn, and maintained on constant
light until late August and then simulated natural photoperiod
thereafter, under an ambient water temperature (range: winter, 3e
summer, 15 C) to produce S1þ smolts. Fish were fed a commercial
diet (BioMar Inicio Plus), distributed by automatic feeders (ARVO-
TEK). Speciﬁc feeding rates (% tank biomass per day) were adjusted
automatically according to predicted growth and daily tempera-
ture, and pellet size (0.5 mme2.0 mm) increased with ﬁsh size.
Mortality between ﬁrst feeding and vaccination was 1.18% for dip-
loids and 1.99% for triploids. On 21st January 2014, ﬁsh were
transferred from the NBFRF to 0.1 m3 tanks (100 L; 1 L min1 ﬂow
rate) at the Aquaculture Research Facility (ARF), University of Stir-
ling, where water temperature was maintained at 9.6 ± 1.1 C and
ﬁsh were fed a 0.5% biomass diet.2.2. Vaccination and sampling
Fish were vaccinated on 11th November 2013 (5 C) using a
commercial vaccination gun (Fishjector 0.1, Kaycee Veterinary
Products, UK). Initial mean weight (±SEM) was 71.4 ± 2.74 g and
58.5 ± 3.57 g for diploids and triploids, respectively. Fish from both
ploidy were divided into three treatment groups in triplicate tanks
(60 ﬁsh tank1), sedated using MS-222 (Pharmaq AS, Oslo, Nor-
way), and then injected intraperitoneally (IP) as follows: (1) sham
injected (0.02M phosphate buffered saline, PBS group); (2) injected
with adjuvant alone (liquid parafﬁn adjuvant, PHARMAQ AS, Oslo,
Norway) (ADJ group); or (3) injected with commercial vaccine
against furunculosis and infectious pancreatic necrosis (ALPHA
JECT 2.2® vaccine, PHARMAQ AS, Oslo, Norway) (VACC group).
Following injection, ﬁsh were transferred into their designated
1 m2 triplicate tank (280 L; 1 L min1 ﬂow rate) for recovery. They
remained on the same feeding regime, photoperiod and water
temperature as previously described.
Sampling was undertaken at 5 time-points post-vaccination (50,
250, 450, 600 and 750D) with 3 ﬁsh sampled per tank at each
time-point (9 ﬁsh per treatment). Weight was assessed prior to
challenge at 750D. At all time-points, each ﬁsh was assessed for
adhesion severity according to the Speilberg Scale [30]. Blood
samples were taken from the caudal vein and the serum collected
before being stored at 20 C. Serum from 50 to 750D were used
to assess complement activity and antibody response, respectively.
A portion of the blood sampled at 50Dwas also removed for blood
cell counts. At 50D, head kidney was dissected from the ﬁsh under
aseptic conditions for assessment of macrophage activity.2.3. Assessment of immune parameters
All immune parameters were assessed at 50D with the
exception of antibody response which was assessed/analysed at
750D.2.3.1. Blood cell counts
Following blood sampling, red blood cell (RBC) and white blood
cell (WBC) counts were carried out according to Morgan et al. [31].
Cell counts were adjusted and expressed as cells x 104 ml1.
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2.3.2.1. Head kidney macrophage isolation. Isolation of head kidney
macrophages was performed according to Secombes [32], with
modiﬁcations. Head kidney was homogenised through a 100 mm
nylon mesh with 5 ml L-15 medium (Sigma, UK) containing 10 ml
heparin (50 mg ml1) (Sigma, UK). Cell suspensions were layered
onto 34%/51% Percoll gradients and centrifuged at 400 g for 30 min
at 4 C. The band of cells at the 34e51% interface was transferred
into 15 ml centrifuge tubes and the volume adjusted to 15 ml with
L-15 medium. Suspensions were centrifuged at 600 g for 7 min at
4 C. The resultant cell pellets were re-suspended in 1 ml L-15
medium containing 5% foetal calf serum (Sigma, UK) and 1% po-
tassium benzyl-penicillin/streptomycin sulphate (Sigma, UK). Cells
were counted using a Neubauer haemocytometer and cell con-
centrations adjusted to 1  107 cells ml1.
2.3.2.2. Respiratory burst. Respiratory burst activity was carried out
according to Morgan et al. [31].
2.3.2.3. Phagocytosis. The phagocytic activity of head kidney mac-
rophages was assessed according to the method described by
Thompson et al. [33], with modiﬁcations. Two circles were marked
on glass slides using an ImmEdge pen (Vector Laboratories Inc, UK).
Cell suspensions were added (100 ml circle1) and slides incubated
for 1 h in a humid chamber. Non-adherent cells were then removed
with L-15 medium. A 0.5% (w/v) yeast (Saccharomyces cerevisiae)
suspension was then added to one circle (100 ml) and L-15 medium
(100 ml) to the other as a negative control. Slides were incubated as
previously described and washed with L-15 medium. Cells were
ﬁxed for 5 min with 100% methanol (100 ml circle1) and then
washed ﬁve times with 70% methanol. Slides were stained with a
Rapid Romanowsky staining series (TCS Biosciences Ltd, UK). Two
hundredmacrophages were examined by strategically scanning the
slide from one side to the other using light microscopy (100x) and
counted, along with the number of yeast per macrophage. Phago-
cytic activity, (PA), phagocytic index (PI) and phagocytic capacity
(PC) were determined according to Findlay and Munday [35], using
the following calculations: Phagocytic activity (PA) ¼ (number of
phagocytising macrophages/total number macrophages  100);
Phagocytic index (PI) ¼ (total number of yeast cells consumed/
number of consuming macrophages); Phagocytic capacity
(PC) ¼ (total number of macrophages containing a given number of
yeast cells/total number of macrophages containing any yeast).
2.3.3. Alternative complement pathway
Spontaneous haemolytic activity was determined by adapting
the method described by Langston et al. [34]. Brieﬂy, serum sam-
ples (in duplicate) were doubly diluted in 0.1% gelatine veronal
buffer (GVB) (1 complement ﬁxation tablet (Oxoid, UK), 0.1 g
gelatine) in a U-well microplate (Fisher Scientiﬁc, UK) (ﬁnal volume
25 ml well1). A 5% (v/v) sheep red blood cell (SRBC) suspensionwas
then added to all wells (10 ml well1). Each microplate also con-
tained control wells. As a positive control, producing 100% SRBC
lysis, 0.1% (w/v) anhydrous Na2CO3 was added to wells in place of
serum samples. As a negative control, eliciting 0% lysis of SRBC, 0.1%
GVB replaced serum samples. All samples were incubated for
90 min at RT with constant shaking, after which the reaction was
stopped by adding GVB containing 20 mM ethylenediaminetetra-
acetic acid (EDTA) (Sigma, UK) (140 ml well1). The microplates
were centrifuged at 750 g for 6 min before supernatants were
transferred into ﬂat-well microplates (Fisher Scientiﬁc, UK) (100 ml
well1). The absorbance was measured at 450 nm. The percentage
lysis for each sample and dilution was calculated using control
values. The dilution that produced 50% lysis was determined using
PROBIT analysis and the reciprocal expressed as spontaneouscomplement haemolysis (SCH50%).
2.3.4. Enzyme linked immunosorbent assay (ELISA)
The speciﬁc antibody response of diploid and triploid Atlantic
salmon to A. salmonicida was measured using the methods
described by Erdal and Reitan [35] and Romstad et al. [36], using
sonicated antigen to coat the ELISA plates as described. Brieﬂy, 96
well microplates (Immulon 4HBX, Fisher Scientiﬁc, UK) were
coated with sonicated whole cell Aeromonas salmonicida MT423,
diluted to 20 mg ml1 in coating buffer (100 ml well1). The plates
were incubated overnight at 4 C, washed with low salt wash buffer
(LSWB: 0.02 M Tris, 0.38 M NaCl, 0.05% Tween 20) and post-coated
for 2 h at room temperature (RT) (i.e. 20 C) with 3% (w/v) casein
(250 ml well1). Doubling serum dilutions were added to the
microplates along with PBS as a negative control (100 ml well1)
and incubated overnight at 4 C. Themicroplates were thenwashed
with high salt wash buffer (HSWB: 0.02 M Tris, 0.5 M NaCl, 0.1%
Tween 20), incubating for 5 min on the last wash. Microplates were
incubated for 1 h at RT with rabbit anti-trout polyclonal antibody
(Aquatic Vaccine Unit, University of Stirling, Stirling, UK), diluted
1:1000 with PBS (100 ml well1). After washing with HSWB, con-
jugate (anti-rabbit-Horseradish peroxidase, Sigma-Aldrich, USA)
diluted 1:2000 with conjugate buffer (1 g bovine serum albumin
(BSA) (Fisher, UK) in 100 ml LSWB), was added for 1 h (100 ml
well1). The reaction was developed by the addition of chromogen
(30305050-Tertamethylbenzidine dihydrochloride) in substrate buffer
(0.1 M citric acid, 0.1 M sodium acetate, pH 5.4) (100 ml well1) and,
after 10 min, was stopped with 2 M sulphuric acid (H2SO4) (50 ml
well1). Absorbance was measured at 450 nm and is expressed as
optical density (OD).
2.4. Vaccine efﬁcacy testing
The strain of A. salmonicida used for the experimental infection
(‘Hooke’) following vaccination was kindly provided by Dr D. A.
Austin, Heriot Watt University. The challenge dose was pre-
determined using three doses (6  103, 6  102 & 6  101 CFU
ﬁsh1) with the two highest doses resulting in 100% mortality and
the lowest giving 83% mortality, and the latter dose was subse-
quently used in the infection trial. At challenge (870D post-
vaccination, 24th March 2014), the mean weights (±SD) of dip-
loids and triploids were 74.6 ± 13.2 g and 61.7 ± 12.5 g, respectively.
Twenty ﬁsh from each triplicate ploidy/treatment tank were
anaesthetised and injected IP with a 0.1 ml dose of A. salmonicida
suspension (4  102 CFU ml1; ﬁnal concentration 4  101 CFU
ﬁsh1). Following injection, ﬁsh were immediately transferred into
their designated 0.1 m3 experimental challenge tanks (100 L;
1 L min1 ﬂow rate) and allowed to recovery. As mortalities
occurred, swabs from head kidney and spleen were sampled on to
brain heart infusion agar (BHIA) (Oxoid, UK) plates for identiﬁca-
tion to conﬁrm speciﬁc mortalities. Following termination of the
challenge (11th April 2014), survivors were sacriﬁced and a random
selection sampled to conﬁrm bacterial recovery or clearance from
vaccinated ﬁsh.
2.5. Statistical analysis
Minitab software version 16 (Minitab Inc., Pennsylvania) was
used to perform basic descriptive statistics and comparisons using a
signiﬁcance level of 5% (P ¼ 0.05). Prior to analysis, datasets were
checked for normality using the Anderson-Darling test. Where
appropriate log transformations where performed to normalise the
data. Post-hoc analyses were carried out using Tukey's multiple
comparison tests with values considered signiﬁcantly different at
P-values <0.05. General linear model (GLM) manipulated to three-
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score, with ploidy, treatment and time (sampling point) considered
ﬁxed factors. Further two-way ANOVAs were carried out for weight
at 750D, blood cell counts, respiratory burst, phagocytosis, com-
plement activity, antibody response and challenge mortalities us-
ing only ploidy and treatment as ﬁxed factors.
3. Results
3.1. Growth
At 750D post vaccination, there was no signiﬁcant difference in
the weight of ﬁsh between the vaccinated and unvaccinated
groups. For the diploid ﬁsh, their mean weight (±SD) was
79.5 ± 12.4 g, 74.7 ± 15.2 g and 69.4 ± 10.2 g for the PBS, ADJ and
VACC groups, respectively. The mean weight of the triploid groups
(PBS, ADJ and VACC) was 66.1 ± 12.5 g, 57.1 ± 11.5 g and
62.3 ± 12.3 g, respectively.
3.2. Adhesion score
Ploidy did not have a signiﬁcant effect on adhesion score
throughout the course of the trial (Fig 1). Treatment had a signiﬁ-
cant effect on adhesion score with adhesions found in ﬁsh injected
with adjuvant and vaccine, as early as 50D. Differences between
treatments (PBS, ADJ, VACC) were signiﬁcant from 250D onwards,
with adhesion scores reached a mean peak value of 2.7 ± 0.2 at
600D in the VACC groups (Fig. 1).
3.3. Immune response
Diploid ﬁsh had higher WBC counts than their triploid coun-
terparts in all treatment groups, but only signiﬁcantly in the VACC
ﬁsh (Fig. 2A). A similar pattern was observed for RBC counts, with
diploids showing signiﬁcantly higher numbers than triploids in the
ADJ group (Fig. 2B). For diploid ﬁsh, WBC counts in the ADJ group
were signiﬁcantly lower than the PBS or VACC groups, while the
triploid PBS group showed signiﬁcantly higher WBC counts than
the other two groups. In contrast, no signiﬁcant treatment differ-
ences were observed for RBC counts.Time (odays)
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Fig. 1. Adhesion score (mean ± SEM, n ¼ 9) in diploid (black) and triploid (grey)
Atlantic salmon injected with PBS (circles), ADJ (squares) or VACC (triangles). Signiﬁ-
cant differences between ploidy/treatments at a given time-point are indicated by
different lowercase superscripts. Signiﬁcant differences relative to 50D are indicated
by asterisk (*).Triploid ﬁsh exhibited signiﬁcantly higher respiratory burst
activity by head kidney macrophages compared to diploids for all
groups (Fig. 2C). Treatment did not have a signiﬁcant effect on
respiratory burst.
No differences in complement activity were observed between
ploidy and this was not inﬂuenced by vaccination (Fig. 2D).
Macrophages of PBS injected triploid ﬁsh had a signiﬁcantly
higher phagocytic index (Pi) than their diploid counterparts, while
the opposite was found for macrophages from the VACC groups
(Fig. 2E). Within the triploid groups, the VACC group was found to
have signiﬁcantly lower Pi than the PBS and ADJ groups, while no
signiﬁcant differences were evident between the diploid groups.
Ploidy was not found to have a signiﬁcant effect on phagocytic
activity (Pa) (Fig. 2F). Within the triploid group, the VACC group
showed signiﬁcantly lower Pa than the PBS group. No signiﬁcant
effect following vaccination was observed in the diploid ﬁsh.
Signiﬁcant differences in phagocytic capacity were noted be-
tween ploidy (Table 1). In the PBS groups, diploid macrophages
phagocytosed a signiﬁcantly higher percentage of low yeast
numbers (e.g. 1, 2), while triploid macrophages were found to
consume signiﬁcantly more high yeast numbers (e.g. 5, 6, 7, þ). No
statistical signiﬁcance was noted between ploidy in the ADJ groups,
but a similar pattern to that of PBS groups was observed. For the
VACC groups, the opposite pattern was noted, with triploids
consuming a higher percentage of low yeast numbers (1 & 2) and
diploid macrophages consuming a signiﬁcantly greater percentage
of high yeast numbers (4, 6 & 7).
The antibody responses of all diploid and triploid groups were
assessed at 750D. There was no effect of ploidy on antibody
response in any of the treatment groups examined (Fig. 3). Signif-
icantly greater antibody responses were elicited in both VACC
groups compared to their respective ADJ and PBS controls.
3.4. Vaccine efﬁcacy testing
Following challenge with Aeromonas salmonicida, mortalities
increased over time in both the PBS and ADJ groups while it
remained low in the VACC groups (Fig. 4). Final mortality was not
signiﬁcantly different between ploidy for any of the treatment
groups (Diploid PBS 95%, ADJ 88.3%, VACC 1.7%; Triploid PBS 98.3%,
ADJ 90%, VACC 5%). Both diploid and triploid VACC groups had
signiﬁcantly lower mortalities compared to the PBS and ADJ groups
(Fig. 4). Relative percent survival (RPS) for the diploid and triploid
VACC groups was 98.3% and 94.9%, respectively. Speciﬁc mortalities
were conﬁrmed by the presence of A. salmonicida in swabs taken
from the kidney and spleen of infected ﬁsh. Aeromonas salmonicida
was isolated from all ﬁsh that died during the challenge and was
conﬁrmed by the appearance of dark/brownpigmented agar and by
Gram stains. No A. salmonicida was recovered from any of the
challenge survivors.
4. Discussion
The response of diploid and triploid Atlantic salmon siblings to
vaccination with a commercial furunculosis vaccine was compared
in the present study, as well as injected with either PBS or adjuvant
alone, used as control groups. Innate immune responses were
examined in these ﬁsh at 50D and antibody responsewas assessed
at 750D, together with the level of protection elicited by the
furunculosis vaccine. Side effects from vaccination e.g. growth and
adhesions were examined throughout the trial as previous reports
indicate poorer growth and more severe adhesions in triploids as a
result of vaccination [29]. The main ﬁndings from this study indi-
cate that triploid Atlantic salmon respond equally as well to
vaccination as diploids, and ploidy does not signiﬁcantly affect the
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Fig. 2. Comparison of (A) white and (B) red) blood cell counts, (C) respiratory burst activity, (D) complement activity (SCH 50%), (E) phagocytic index and (F) activity (Pa, %) between
diploid (black) and triploid (grey) Atlantic salmon injected either PBS, adjuvant (ADJ) or vaccine (VACC) at 50D. Values expressed as means ± SEM (n ¼ 9). Signiﬁcant differences are
indicated by different letters.
Table 1
Comparison of phagocytic capacity between diploids and triploids in each treatment group.
Active macrophages consuming a given number yeast cells (%)
Treatment Ploidy 1 2 3 4 5 6 7 þ
PBS Diploid 39.3a ± 2.6 24.7a ±2.8 16.8 ± 4.1 8.7 ± 1.5 4.9b ± 1.8 2.4b ± 1.2 1b ± 0.7 2.2b ± 1.2
Triploid 25.7b ± 4.7 19.2b ± 2.7 16.0 ± 2.7 12.9 ± 3.6 10.0a ± 2.0 5.4a ± 0.9 5.2a ± 1.6 5.6a ± 1.9
ADJ Diploid 33.5 ± 6.1 20.2 ± 1.4 18.0 ± 3.1 9.9 ± 2.8 9.0 ± 1.6 3.1 ± 1.0 3.4 ± 1.2 3.0 ± 2.0
Triploid 35.7 ± 7.2 19.0 ± 5.9 13.6 ± 4.6 8.9 ± 1.3 6.8 ± 2.4 5.5 ± 2.2 5.0 ± 2.3 4.5 ± 2.3
VACC Diploid 31.2 ± 7.7 15.8 ± 1.5 14.4 ± 3.0 10.2a ± 1.3 8.9 ± 3.1 5.6a ± 1.8 5.8a ± 1.7 8.1 ± 3.5
Triploid 46.0 ± 9.3 17.3 ± 5.7 10.6 ± 3.6 5.7b ± 2.6 5.4 ± 1.8 2.3b ± 1.6 2b ± 1.6 10.8 ± 5.3
Signiﬁcant differences between ploidy are indicated by different lowercase superscripts.
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Fig. 3. Comparison of antibody response (OD450nm) between diploid (black) and
triploid (grey) Atlantic salmon injected either PBS, adjuvant (ADJ) or vaccine (VACC) at
750D. Values expressed as means ± SEM (n ¼ 9). Signiﬁcant differences are indicated
by different letters.
Fig. 4. Cumulative mortality (%) of diploid (black) and triploid (grey) Atlantic salmon
injected either PBS, adjuvant (ADJ) or vaccine (VACC) then experimental infected with
Aeromonas salmonicida. Values expressed as mean treatment group mortality (%) ±SEM
(n ¼ 3). Signiﬁcant differences between groups are indicated by different letters.
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signiﬁcantly affected by ploidy, with similar relative percent sur-
vival values obtained for both diploid (98.3%) and triploid (94.9%)
ﬁsh.
The growth performance of triploids is much debated
[10,11,15,17], with triploid growth following vaccination relatively
uncharacterised, and although vaccination did not have a signiﬁ-
cant effect on weight in triploids compared to diploids or unvac-
cinated ﬁsh in our study, there are reports of a reduction in weight
in triploids post-vaccination from other studies [3,29,37]. It should
be noted that our study was only performed for 4 months in
freshwater, while the other studies cited lasted for considerably
longer in both fresh- and seawater [3,29]. While non-signiﬁcant
effects of vaccination were observed on growth in this study, sup-
porting the use of commercial vaccines in triploid Atlantic salmon,
it is recommended that vaccination should be assessed over a full
production cycle.
Vaccination is known to produce other side-effects includinginternal abdominal adhesions [29,38,39]. This has serious impli-
cations at harvest, as adhesions can lead to downgrading carcass
quality [40,41]. Due to the limited assessment of the vaccination
process in triploid Atlantic salmon, much is still unknown about the
relationship between vaccines, their side-effects and triploids. In
this study, ploidy did not have a signiﬁcant impact on the severity
of adhesion scores observed in diploid and triploid ﬁsh. This ﬁnding
is supported by previous vaccination studies using S1þ triploid
smolts, which in fact were conducted over a longer time scale
[19,29]. Vaccination did result in adhesions in both ploidies, with
adjuvant alone also inducing adhesions. The PBS group of both
ploidy groups consistently showed little evidence of adhesions, as
expected. From 250D onwards, adhesion scores in the VACC
groups were signiﬁcantly higher than both the PBS and ADJ groups,
with adhesion scores in the ADJ group signiﬁcantly higher than
those of the PBS group. These results agree with previous studies,
which found that while adjuvants alone could cause adhesions,
vaccines and thus the inclusion of an antigen increased the severity
of adhesion scores [30,38,42,43]. Signiﬁcant differencewas noted in
the ADJ groups between ploidies at 750D, where triploid adhesion
scores were signiﬁcantly lower than that of diploid and may indi-
cate that triploids recover more quickly from the effects of adhe-
sions than diploids, but a longer trial would help elucidate this.
From the results of this study, however, it can be suggested that
triploid Atlantic salmon experience the same degree of side-effects
as diploids.
Before being able to produce triploid ﬁsh commercially, it is
essential that their health and immunity be carefully assessed
compared to diploid counterparts [24]. Numerous studies have now
been undertaken to investigate this, with reports of greater or equal
disease resistance in triploids compared to diploids [3,24,34,56]. As
such, much remains to be elucidated about the effects of triploidy
on health and immunity. In this study, ploidy appeared to have an
effect on some of the immune parameters measured.
Ploidy had an effect on WBC and RBC counts, with triploids
showing lower cell numbers compared to diploids. It is recognised
that the third chromosome possessed by triploids is compensated
for by increased cell size and reduced cell number and since the late
1950's, numerous studies have supported this, with reduced cell
numbers continually observed in triploids [44e47]. In terms of
treatment effects, WBC counts were the lowest in both the ADJ
groups and the triploid VACC group. Following vaccination, it
would be expected that WBC numbers in the VACC groups increase
over that of the controls. From vaccination to the 50D sampling
point, the water temperature was low (4.9 ± 0.2 C) and so, it could
be suggested that low temperature had suppressive effect on the
WBC's of the innate immune response and the levels remain basal.
In a previous study on diploid rainbow trout, similar cell volumes
were recorded at the same temperature observed in this study [31].
Variation can also be seen in RBC counts between treatment
groups, with similar levels previously exhibited in rainbow trout
[31]. As such, with RBC's not playing a major role in the immune
response, it could be suggested that the numbers observed are of
normal population variation.
Ploidy had a signiﬁcant effect on the activity of head kidney
macrophages. Respiratory burst in triploids was signiﬁcantly higher
than in diploids, with the triploids consistently showing more than
double their activity. This ﬁnding may also reﬂect the compensa-
tory mechanism employed by triploid ﬁsh to deal with the reduced
number of cells present and supported by previous studies which
found increased activity in triploids compared to diploid counter-
parts [24,47]. Treatment was not found to have a signiﬁcant effect
on respiratory burst. Given previous research which showed
increased respiratory burst following vaccination or exposure to an
antigen [48e50], it was expected that the respiratory burst activity
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could again be suggested that the low temperature experienced
during this study was having a suppressive effect on the respiratory
burst activity in the VACC groups. This is supported by a previous
study in diploid rainbow trout which showed similar respiratory
burst activity to that recorded in this study, at the same
temperature.
In terms of phagocytosis, varied pattern of activity were recor-
ded. Considering previous studies, triploids would be expected to
show increased activity during phagocytosis [24,51] but neither
diploid nor triploid head kidney macrophages consistently showed
increased activity. It would also be expected that Pi and Pawould be
higher in the VACC group due to antigen stimulation of the immune
response. In terms of triploid phagocytosis (i.e. Pi and Pa values),
lower values were recorded in the VACC groups compared to the
controls. It could be suggested that while vaccines stimulate the
ﬁsh's immune response, the overall reduction in cell number in
triploids may have had an effect on the overall number of yeast
being consumed. Further research is needed to understand the
compensatory mechanisms that may occur in triploid leucocytes,
particularly macrophages, in relation to genome regulation and
gene expression.
In addition, a greater percentage of triploid macrophages had a
higher phagocytic capacity (Pc), consuming greater numbers of
yeast cells (i.e. between 5 and 7) compared to diploid ﬁsh in the PBS
and ADJ groups. Budi~no et al. [24], also showed that the lower cell
numbers observed in triploids may be compensated for by
increased cellular activity, and due to their larger size, the cells have
higher membrane surface and volume than diploid cells, thus
increasing their ability to engulf particles.
No signiﬁcant differences in ploidy were observed in comple-
ment activity (SCH50%). The results obtained concur with the
ﬁndings of a 19 day study undertaken by Langston et al. [34], in
which a decrease in the ACH50%was observed for both ploidies at 2
and 3 days post-injection with lipopolysaccharide. In our study,
complement activity was only measured at 50D (8 days post-
injection), which suggests that the early changes observed by
Langston et al. [34] may have beenmissed, and the results obtained
reﬂect recovering activity levels, and further vaccination trials
should be undertaken to assess ploidy differences in complement
activity at earlier time-points. Complement activity was lowest in
the PBS injected group, followed by ADJ group, with the VACC
group exhibiting the highest activity, although not signiﬁcantly
different. Other studies have found increased complement activity
in vaccinated ﬁsh compared to unvaccinated controls [52,53].
In this study, antibody response was assessed at 750D post-
vaccination, and ploidy was not found to have a signiﬁcant effect
on the antibody response obtained. There was, however, a trend for
triploids to have greater antibody response than the diploids. This is
supported by the results from Kusuda et al. [51], who revealed a
non-signiﬁcant trend for greater agglutinating antibody titres in
triploid ayu (Plecoglossus altivelis). It is encouraging that triploids
are able to produce similar levels of antibodies to diploids. There
was a signiﬁcant treatment effect on antibody response within the
ploidy groups, with higher antibody responses recorded in vacci-
nated ﬁsh compared to the non-vaccinated groups, in accordance
with other studies [35,48]. The antibody response obtained in
vaccinated ﬁsh was lower than expected, from other studies
examining antibody responses in ﬁsh vaccinated against furuncu-
losis [35,36], possibly due to the vaccination temperature used
[54,55], however this ultimately did not affect the efﬁcacy elicited
by the vaccine.
Vaccine efﬁcacy was conﬁrmed by comparing the level of
mortalities in each ploidy/treatment group when experimentally
infectedwith A. salmonicida. Whilemuch is still unknown about theeffect of ploidy on disease resistance [13], numerous studies
investigating this issue have demonstrated equal or greater disease
resistance in triploid [3,24,34,56]. This study is clearly in support of
this as no signiﬁcant effect of ploidy on mortality was evident.
In conclusion, this study showed that a commercial furunculosis
vaccine was equally effective in protecting diploid and triploid
Atlantic salmon from infection by A. salmonicida, and ploidy did not
affect the severity of the adhesions that occurred in vaccinated ﬁsh.
The immune response of the ploidies were found to differ, however,
with increased respiratory burst observed in triploids. It has been
suggested that the differences seen may due to a compensatory
mechanism for the reduced number of cells present in triploids.
Ploidy also did not have a signiﬁcant effect on levels of mortalities
or vaccine efﬁcacy during an experimental infection with
A. salmonicida post-vaccination. Overall, the ﬁndings of this study
contribute to knowledge that triploid salmon appear to be as robust
as diploid siblings and provides a base for further research into the
immune response of triploid Atlantic salmon.
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